Logo image of VIE

Viela Bio Inc (VIE) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:VIE -

53.01
0 (0%)
Last: 3/12/2021, 8:00:01 PM
53.04
+0.03 (+0.06%)
After Hours: 3/12/2021, 8:00:01 PM

VIE Key Statistics, Chart & Performance

Key Statistics
Market Cap2.91B
Revenue(TTM)11.65M
Net Income(TTM)-150.67M
Shares54.95M
FloatN/A
52 Week High65
52 Week Low25.02
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.83
PEN/A
Fwd PEN/A
Earnings (Next)02-08 2022-02-08/amc
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


VIE short term performance overview.The bars show the price performance of VIE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

VIE long term performance overview.The bars show the price performance of VIE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of VIE is 53.01 null. In the past month the price increased by 0.38%. In the past year, price increased by 35.64%.

Viela Bio Inc / VIE Daily stock chart

VIE Latest News, Press Relases and Analysis

About VIE

Company Profile

Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.

Company Info

Viela Bio Inc

1 MEDIMMUNE WAY

GAITHERSBURG MD 20878

CEO: Zhengbin (Bing) Yao

Phone: 240-780-6356

Viela Bio Inc / VIE FAQ

What does VIE do?

Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.


Can you provide the latest stock price for Viela Bio Inc?

The current stock price of VIE is 53.01 null.


Does VIE stock pay dividends?

VIE does not pay a dividend.


What is the ChartMill rating of Viela Bio Inc stock?

VIE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of Viela Bio Inc (VIE) based on its PE ratio?

Viela Bio Inc (VIE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.83).


Can you provide the upcoming earnings date for Viela Bio Inc?

Viela Bio Inc (VIE) will report earnings on 2022-02-08, after the market close.


VIE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to VIE. When comparing the yearly performance of all stocks, VIE turns out to be only a medium performer in the overall market: it outperformed 41.15% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

VIE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to VIE. While VIE seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VIE Financial Highlights

Over the last trailing twelve months VIE reported a non-GAAP Earnings per Share(EPS) of -2.83. The EPS increased by 59.69% compared to the year before.


Industry RankSector Rank
PM (TTM) -1293.07%
ROA -35.6%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%25%
Sales Q2Q%-68.88%
EPS 1Y (TTM)59.69%
Revenue 1Y (TTM)-76.7%

VIE Forecast & Estimates


Analysts
Analysts70
Price TargetN/A
EPS Next Y0.71%
Revenue Next YearN/A

VIE Ownership

Ownership
Inst Owners0.43%
Ins Owners0.21%
Short Float %N/A
Short RatioN/A